HIV Cure

unnamed(1)

On-Demand Educational Activity

What Clinicians Want to Know: A Webinar on the Safe Conduct of HIV Cure-Related Trials

90 MInutes

FREE
CME/CNE/CPE Available
Release date

October 6th, 2026

Expiration date

October 6th, 2027

Supported by Independent Educational Grants from Gilead Sciences and Merck 

Why This Activity Matters

As HIV cure-related clinical trials continue to evolve, HIV care teams are increasingly asked to answer questions about HIV cure research, analytical treatment interruptions (ATIs), and clinical trial participation. This interactive webinar will help clinicians understand the current science, communicate effectively with patients, and collaborate with research teams while supporting safe, patient-centered care. Unique to this webinar, participants will hear from HIV cure researchers, frontline HIV clinicians, and a former HIV cure trial participant, offering scientific, clinical, and community perspectives on the safe conduct of HIV cure-related trials. Patients are hearing more about HIV cure research and increasingly look to their HIV care teams for guidance. Yet many clinicians feel uncertain about discussing analytical treatment interruptions (ATIs), addressing patient questions, or understanding how clinical care and research teams work together during cure-related studies. This webinar provides practical, evidence-based guidance on the current state of HIV cure research, the purpose and safeguards of ATIs, and strategies for counseling patients and collaborating with research teams before, during, and after ATI studies. Whether or not you participate in HIV cure research, you may care for patients who ask about cure-related clinical trials or are considering enrollment.

Learning Objectives

What You'll Take Back to Practice

Meet the Faculty

Moderator
Interprofessional Panelists:

Accreditation & Available Credit

All other members of the care team will receive a certificate of participation.

In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc., University of Pennsylvania and The Wistar Institute. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

American Academy of CME, Inc., designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Academy of CME, Inc., designates this educational activity for 1.5 ANCC contact hours (0.15 pharmacotherapeutic contact hours).

California

Provider approved by the California Board of Registered Nursing, Provider Number CEP16993 for 1.5 contact hours.

American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until October 6, 2027. PAs should only claim credit commensurate with the extent of their participation.

This activity provides 1.0 ACPE contact hours (0.1 CEUs) of continuing education credit. Universal Activity Number JA4008191-9999-26-086-H02-P, Knowledge.

Disclosures

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible companies. The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.

Faculty Educator Disclosures

Edward Kreider, MD, PhD, Arianne S. Morrison, MD, MSCR, Jillian Baron, MD, MPH, and William Carter-No relevant financial relationships to disclose.

Katharine Bar, MD-Advisory Board/Consultant: ViiV Healthcare, Merck, AbbVie; Grant/Research Support: Merck, ViiV Healthcare; DSMB: AbbVie (relationship ended)

Karine Dubé, DrPH, MPhil-Advisory Board/Consultant: Gilead Sciences, ViiV Healthcare; Grant/Research Support: Merck

Ashwin K. Gupta, PA-C-Advisory Board/Consultant: Gilead Sciences; Speaker’s Bureau: Gilead Sciences

Steven Meanley, PhD, MPH- Grant/Research Support: Gilead Sciences

Luis J. Montaner, DVM, MSc, DPhil-Advisory Board/Consultant: Merck, GeneOne Biosciences, Sauvie; Public Stockholder: Inovio; Speaker’s Bureau: Gilead Sciences

Karam Mounzer, MD-Advisory Board/Consultant: ViiV Healthcare, Gilead Sciences, Merck, Epividian; Grant/Research Support: ViiV Healthcare, Merck, Gilead Sciences; Speaker’s Bureau: ViiV Healthcare, Merck, Gilead Sciences

Pablo Tebas, MD-Advisory Board/Consultant: Merck, ViiV Healthcare

Planning Team Disclosures

Jonathan Colasanti, MD; Courtney Fletcher, PharmD; Jose Gutierrez, PhD, FNP-BC; Margaret Hoffman-Terry, MD, FACP, AAHIVS; John JD Juchniewicz, MCIS, CHCP, FACEHP; H. Nina Kim, MD, MS; Natalie Kirkwood, RN, BSN, JD; Daiquiri Y. Robinson, Med, Matthew Young: No relevant financial relationships to disclose.
Christopher Evans, MD: Grant/Research Support: ViiV Healthcare
William R. Short, MD, MPH: Advisory Board/Consultant – ViiV Healthcare, Gilead Sciences; Grant/Research Support – Gilead Sciences
Sarah Smith, MHS, PA-C, AAHIVS: Advisory Board/Consultant: ViiV Healthcare, Gilead Sciences, Merck, Janssen*; Speaker’s Bureau: ViiV Healthcare, Gilead Sciences, Merck, Janssen*
*Relationship has ended

Off-Label Disclosure

This activity contains discussion of off-label and investigational agents.

The opinions expressed in this accredited continuing education activity are those of the faculty, and do not represent those of the Academy/ACTHIV Institute. This educational activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.

Implicit Bias: Implicit bias refers to unconscious attitudes and stereotypes that influence our thoughts, judgements, decisions, and actions without our awareness. Everyone is susceptible to implicit bias, even clinicians. In healthcare, implicit biases can have a significant impact on the quality of care an individual receives. These biases can be both favorable and unfavorable, and are activated involuntarily without an individual’s awareness or intentional control. Studies have indicated that healthcare providers’ incorrect perceptions can impact providers’ communications and clinical decision-making contributing to disparities in clinical outcomes. Addressing implicit biases in healthcare is critical to improving health outcomes and promoting health equity for all patients. Patient-centered care can reduce the impact of implicit bias, by treating each patient as a unique individual who may or may not hold beliefs associated with their backgrounds and circumstances. In addition, recognizing implicit bias in one’s own practice using techniques such as self-reflection and mindful clinical decision-making can ensure more equitable and effective care for all patients.

Over the past several decades, cognitive science research has demonstrated human behavior, beliefs and attitudes are shaped by automatic and unconscious cognitive processes. The healthcare profession is devoting greater attention to how these automatic and unconscious processes impact care including: (1) preferential treatment toward or against specific patient populations causing healthcare inequities, (2) influence patient-provider communications leading to misunderstandings and mistrust, and (3) impact access to healthcare and affect treatment decisions resulting in misdiagnosis, delays in treatment and specialty referrals and poor pain management. Considering one might have unconscious biases and exploring them may be uncomfortable because the very idea that they exist may conflict with how clinicians perceive themselves. It is only by becoming aware of one’s unconscious biases that members of the healthcare team can take steps to mitigate them to ensure all their patients receive quality healthcare. For more information on strategies to reduce implicit bias, visit: https://www.ihi.org/library/blog/how-reduce-implicit-bias

For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm

For any questions, please contact: [email protected].

This program should be viewed at a resolution of 1024 x 768 or higher using current versions of Microsoft Internet Explorer, Firefox, Chrome or Safari. A high-speed Internet connection is recommended.

© 2026. This accredited continuing education activity is held as copyrighted © by American Academy of CME, University of Pennsylvania and The Wistar Institute. Through this notice, permission is granted for its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).